This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bosch C., Muhaisen A., Pujadas L., Soriano E., Martínez A.: Reelin Exerts Structural, Biochemical and Transcriptional Regulation Over Presynaptic and Postsynaptic Elements in the Adult Hippocampus. Frontiers in Cellular Neuroscience, 2016, 10: 138.BoschC.MuhaisenA.PujadasL.SorianoE.MartínezA.: Reelin Exerts Structural, Biochemical and Transcriptional Regulation Over Presynaptic and Postsynaptic Elements in the Adult Hippocampus. Frontiers in Cellular Neuroscience, 2016, 10: 138.10.3389/fncel.2016.00138488474127303269Search in Google Scholar
Camfield P., Camfield C.: Incidence, prevalence and etiology of seizures and epilepsy in children. Epileptic Disord., 2015, 17: 117–123.CamfieldP.CamfieldC.: Incidence, prevalence and etiology of seizures and epilepsy in children. Epileptic Disord., 2015, 17: 117–123.10.1684/epd.2015.073625895502Search in Google Scholar
Cárdenas-Rodríguez N., Carmona-Aparicio L., Pérez-Lozano D.L., Ortega-Cuellar D., Gómez-Manzo S., Ignacio-Mejía I.: Genetic variations associated with pharmacoresistant epilepsy. Mol. Med. Rep., 2020, 21: 1685–1701.Cárdenas-RodríguezN.Carmona-AparicioL.Pérez-LozanoD.L.Ortega-CuellarD.Gómez-ManzoS.Ignacio-MejíaI.: Genetic variations associated with pharmacoresistant epilepsy. Mol. Med. Rep., 2020, 21: 1685–1701.10.3892/mmr.2020.10999705782432319641Search in Google Scholar
Choi H., Hayat M.J., Zhang R., Hirsch L.J., Bazil C.W., Mendiratta A. et al.: Drug resistant epilepsy in adults: Outcome trajectories after failure of two medications. Epilepsia, 2016, 57: 1152–1160.ChoiH.HayatM.J.ZhangR.HirschL.J.BazilC.W.MendirattaA.: Drug resistant epilepsy in adults: Outcome trajectories after failure of two medications. Epilepsia, 2016, 57: 1152–1160.10.1111/epi.1340627265407Search in Google Scholar
Depondt C.: The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol., 2006, 10: 57–65.DepondtC.: The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol., 2006, 10: 57–65.10.1016/j.ejpn.2005.11.00916531088Search in Google Scholar
Dutta S., Gangopadhyay P.K., Sinha S., Chatterjee A., Ghosh S., Rajamma U.: An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal. Cell Mol. Neurobiol., 2011, 31: 45–56.DuttaS.GangopadhyayP.K.SinhaS.ChatterjeeA.GhoshS.RajammaU.: An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal. Cell Mol. Neurobiol., 2011, 31: 45–56.10.1007/s10571-010-9551-720697953Search in Google Scholar
Fiest K.M., Sauro K.M., Wiebe S., Patten S.B., Kwon C.-S., Dykeman J. et al.: Prevalence and incidence of epilepsy. Neurology, 2017, 88: 296–303.FiestK.M.SauroK.M.WiebeS.PattenS.B.KwonC.-S.DykemanJ.: Prevalence and incidence of epilepsy. Neurology, 2017, 88: 296–303.10.1212/WNL.0000000000003509527279427986877Search in Google Scholar
Kalilani L., Sun X., Pelgrims B., Noack-Rink M., Villanueva V.: The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia, 2018. https://doi.org/10.1111/epi.14596KalilaniL.SunX.PelgrimsB.Noack-RinkM.VillanuevaV.: The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia, 2018. https://doi.org/10.1111/epi.1459610.1111/epi.1459630426482Search in Google Scholar
Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O. et al.: Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet., 2000, 26: 93–96.HongS.E.ShugartY.Y.HuangD.T.ShahwanS.A.GrantP.E.HourihaneJ.O.: Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet., 2000, 26: 93–96.10.1038/7924610973257Search in Google Scholar
Kang, S.K., Vanoye C.G., Misra S.N., Echevarria D.M., Calhoun J.D., O’Connor J.B. et al.: High throughput Characterization of KCNB1 variants Associated with Developmental and Epileptic Encephalopathy. Bio Rxiv., 2019, 86: 899–912.Kang,S.K.VanoyeC.G.MisraS.N.EchevarriaD.M.CalhounJ.D.O’ConnorJ.B.: High throughput Characterization of KCNB1 variants Associated with Developmental and Epileptic Encephalopathy. Bio Rxiv., 2019, 86: 899–912.10.1002/ana.25607702543631600826Search in Google Scholar
Kovel, C.G.F de, Syrbe S., Brilstra E.H., Verbeek N., Kerr B., Dubbs H. et al.: Neurodevelopmental Disorders Caused by de Novo Variants in KCNB1 Genotypes and Phenotypes. JAMA Neurol., 2017, 74: 1228–1236.Kovel,C.G.F deSyrbeS.BrilstraE.H.VerbeekN.KerrB.DubbsH.: Neurodevelopmental Disorders Caused by de Novo Variants in KCNB1 Genotypes and Phenotypes. JAMA Neurol., 2017, 74: 1228–1236.10.1001/jamaneurol.2017.1714571024228806457Search in Google Scholar
Kwan P., Brodie M.J.: Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.KwanP.BrodieM.J.: Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.10.1056/NEJM20000203342050310660394Search in Google Scholar
Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G. et al.: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia, 2010, 51: 1069–1077.KwanP.ArzimanoglouA.BergA.T.BrodieM.J.Allen HauserW.MathernG.: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia, 2010, 51: 1069–1077.10.1111/j.1528-1167.2009.02397.x19889013Search in Google Scholar
López González F.J., Rodríguez Osorio X., Gil-Nagel Rein A., Carreño Martínez M., Serratosa Fernández J., Villanueva Haba V. et al.: Drug-resistant epilepsy: Definition and treatment alternatives. Neurologia, 2015, 30: 439–446. (In English, Spanish).López GonzálezF.J.Rodríguez OsorioX.Gil-Nagel ReinA.Carreño MartínezM.Serratosa FernándezJ.Villanueva HabaV.: Drug-resistant epilepsy: Definition and treatment alternatives. Neurologia, 2015, 30: 439–446. (In English, Spanish).10.1016/j.nrleng.2014.04.002Search in Google Scholar
Luciano A.L., Shorvon S.D.: Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann. Neurol., 2007, 62: 375–381.LucianoA.L.ShorvonS.D.: Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann. Neurol., 2007, 62: 375–381.10.1002/ana.2106417253624Search in Google Scholar
Marini, C., Romoli M., Parrini E., Costa C., Mei D., Mari F. et al.: Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations. Neurol. Genet., 2017, 3: e206.Marini,C.RomoliM.ParriniE.CostaC.MeiD.MariF.: Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations. Neurol. Genet., 2017, 3: e206.10.1212/NXG.0000000000000206573325029264397Search in Google Scholar
Michelucci R., Pulitano P., Di Bonaventura C., Binelli S., Luisi C., Pasini E. et al.: The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav., 2017, 68: 103–107.MichelucciR.PulitanoP.Di BonaventuraC.BinelliS.LuisiC.PasiniE.: The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav., 2017, 68: 103–107.10.1016/j.yebeh.2016.12.003537890428142128Search in Google Scholar
Myers C.T., Mefford H.C.: Advancing epilepsy genetics in the genomic era. Genome Med., 2015, 7: 91.MyersC.T.MeffordH.C.: Advancing epilepsy genetics in the genomic era. Genome Med., 2015, 7: 91.10.1186/s13073-015-0214-7454912226302787Search in Google Scholar
Sun Y., Seneviratne U., Perucca P., Chen Z., Tan M.K., O’Brien T.J. et al.: Generalized polyspike train: An EEG biomarker of drug-resistant idiopathic generalized epilepsy. Neurology, 2018, 91: e1822–e1830.SunY.SeneviratneU.PeruccaP.ChenZ.TanM.K.O’BrienT.J.: Generalized polyspike train: An EEG biomarker of drug-resistant idiopathic generalized epilepsy. Neurology, 2018, 91: e1822–e1830.10.1212/WNL.000000000000647230315071Search in Google Scholar
Szaflarski J.P., Lindsell C.J., Zakaria T., Banks C., Privitera M.D.: Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response. Epilepsy Behav., 2010, 17: 525–530.SzaflarskiJ.P.LindsellC.J.ZakariaT.BanksC.PriviteraM.D.: Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response. Epilepsy Behav., 2010, 17: 525–530.10.1016/j.yebeh.2010.02.005292321120227351Search in Google Scholar
Téllez-Zenteno J.F., Hernández-Ronquillo L., Buckley S., Zahagun R., Rizvi S.: A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia, 2014, 55: 829–834.Téllez-ZentenoJ.F.Hernández-RonquilloL.BuckleyS.ZahagunR.RizviS.: A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia, 2014, 55: 829–834.10.1111/epi.1263324828683Search in Google Scholar
Torkamani, A., Bersell K., Jorge B.S., Bjork R.L. Jr, Friedman J.R., Bloss C.S. et al.: De novo KCNB1 mutations in epileptic encephalopathy. Ann. Neurol., 2014, 76: 529–540.Torkamani,A.BersellK.JorgeB.S.BjorkR.L.JrFriedmanJ.R.BlossC.S.: De novo KCNB1 mutations in epileptic encephalopathy. Ann. Neurol., 2014, 76: 529–540.10.1002/ana.24263419209125164438Search in Google Scholar
